 Eidos Therapeutics Inc NASDAQ:EIDX Piper Sandler issued their FY2024 earnings per share estimates for Eidos Therapeutics in a research note issued on Wednesday, February 26th. Piper Sandler analyst T. Van. Buren expects that the company will post earnings per share of 1.95 for the year. Piper Sandler has a Overweight rating and a 80.00 ... 